Shanghai, China · Founded 2022 · Privately Held (backing)
Developer of green synthetic biological products. InnoGene BioTech is based in Shanghai, China and was founded in 2022. Its last reported valuation was $27 million in Dec 2022. It has raised $41.5 million.
Last reported valuation
$27.0M
Oct 2026
Priced at
—
Total raised
$41.5M
Last round
—
Cap table — not yet on record
InnoGene BioTech's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of InnoGene BioTech with a free account
·Watch InnoGene BioTech: the Monday email on marks, rounds and moves
